Unknown PHASE3 INTERVENTIONAL NCT00189384

Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants

Randomized Controlled Trial of Intramuscular Ceftriaxone Versus Procaine Penicillin Versus Cotrimoxazole and Gentamicin for Management of Serious Bacterial Infections in Young Infants in Community Settings

Sponsor: Aga Khan University

Conditions Bacterial Infection Infant, Newborn Sepsis

Interventions ceftriaxone, procaine penicillin and gentamicin, oral cotrimoxazole and gentamicin

Updated 5 times since 2017 Last updated: Sep 7, 2006 Started: Nov 30, 2003 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Bacterial Infection and Infant, Newborn and is currently ongoing. Aga Khan University leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Nov 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aga Khan University

Data source: Aga Khan University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan